These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 28074772)

  • 1. [Nuclear medicine techniques for selective internal radiotherapy of liver cancer].
    Staanum PF; Arveschoug AK; Kramer SM; Nielsen JE; Nielsen DT; Ott P; Grønbæk H; Villadsen GE
    Ugeskr Laeger; 2017 Jan; 179(1):. PubMed ID: 28074772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients.
    Sancho L; Rodriguez-Fraile M; Bilbao JI; Beorlegui Arteta C; Iñarrairaegui M; Moran V; Sangro B
    J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can pretreatment hepatic artery perfusion scintigraphy in patients with liver malignancies predict the treatment response of the selective internal radiation therapy with 90Y resin microspheres?
    Guney IB; Balli HT; Kucuker KA; Unal I; Kibar M
    Diagn Interv Radiol; 2022 Mar; 28(2):156-165. PubMed ID: 35548900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.
    Lau WY; Kennedy AS; Kim YH; Lai HK; Lee RC; Leung TW; Liu CS; Salem R; Sangro B; Shuter B; Wang SC
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):401-7. PubMed ID: 20950954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study.
    Kokabi N; Galt JR; Xing M; Camacho JC; Barron BJ; Schuster DM; Kim HS
    J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer.
    Hamami ME; Poeppel TD; Müller S; Heusner T; Bockisch A; Hilgard P; Antoch G
    J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment.
    Ahmadzadehfar H; Sabet A; Biermann K; Muckle M; Brockmann H; Kuhl C; Wilhelm K; Biersack HJ; Ezziddin S
    J Nucl Med; 2010 Aug; 51(8):1206-12. PubMed ID: 20660379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioembolization with infusion of yttrium-90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe.
    Burgmans MC; Kao YH; Irani FG; Dames EL; Teo TK; Goh AS; Chow PK; Tay KH; Lo RH
    J Vasc Interv Radiol; 2012 Oct; 23(10):1294-301. PubMed ID: 22922039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Primary Liver Tumors and Liver Metastases, Part 1: Nuclear Medicine Techniques.
    Voutsinas N; Lekperic S; Barazani S; Titano JJ; Heiba SI; Kim E
    J Nucl Med; 2018 Nov; 59(11):1649-1654. PubMed ID: 30072501
    [No Abstract]   [Full Text] [Related]  

  • 10. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.
    Ho S; Lau WY; Leung TW; Chan M; Ngar YK; Johnson PJ; Li AK
    Eur J Nucl Med; 1996 Aug; 23(8):947-52. PubMed ID: 8753684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technical solutions to ensure safe yttrium-90 radioembolization in patients with initial extrahepatic deposition of (99m)technetium-albumin macroaggregates.
    Barentsz MW; Vente MA; Lam MG; Smits ML; Nijsen JF; Seinstra BA; Rosenbaum CE; Verkooijen HM; Zonnenberg BA; Van den Bosch MA
    Cardiovasc Intervent Radiol; 2011 Oct; 34(5):1074-9. PubMed ID: 21191588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 90Yttrium PET/MR-based dosimetry after liver radioembolization (SIRT).
    Wissmeyer M; Delattre BM; Zaidi H; Terraz S; Ratib O
    Clin Nucl Med; 2015 Apr; 40(4):355-7. PubMed ID: 25674869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of yttrium-90 in the management of unresectable hepatocellular carcinoma and hepatic metastases.
    Kousik V; Promila P; Verma R; Gupta A
    Indian J Gastroenterol; 2016 May; 35(3):179-85. PubMed ID: 27185180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Selective internal radiotherapy (SIRT) for hepatocellular carcinoma].
    Antoch G; Mueller SP; Hamami M; Heusner TA; Ertle J; Hilgard P; Forsting M; Bockisch A
    Rofo; 2010 Aug; 182(8):660-70. PubMed ID: 20405369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioembolization with (90)Y-microspheres for liver tumors].
    Rodríguez-Fraile M; Iñarrairaegui M
    Rev Esp Med Nucl Imagen Mol; 2015; 34(4):244-57. PubMed ID: 25911062
    [No Abstract]   [Full Text] [Related]  

  • 16. 99m Tc-Macroaggregated Albumin Liver Lung Shunt Study With Uptake Indicative of Patent Falciform Artery.
    Namous N; Kushner D; Dadparvar S
    Clin Nucl Med; 2023 Jun; 48(6):510-511. PubMed ID: 36179332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outpatient single-session yttrium-90 glass microsphere radioembolization.
    Gates VL; Marshall KG; Salzig K; Williams M; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors.
    Ilhan H; Goritschan A; Paprottka P; Jakobs TF; Fendler WP; Todica A; Bartenstein P; Hacker M; Haug AR
    J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of catheter-directed CT angiography on yttrium-90 radioembolization treatment of hepatocellular carcinoma.
    Rhee TK; Omary RA; Gates V; Mounajjed T; Larson AC; Barakat O; Sato KT; Mulcahy M; Gordon S; Lewandowski RJ; Salem R
    J Vasc Interv Radiol; 2005 Aug; 16(8):1085-91. PubMed ID: 16105920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres.
    Garin E; Rolland Y; Laffont S; Edeline J
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):559-75. PubMed ID: 26338177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.